Tanshinone IIA protects against immune-mediated liver injury through activation of t-cell subsets and regulation of cytokines

Immunopharmacology and Immunotoxicology

Volumn 32, Issue 1, 2010, Pages 51-55

  Qin, Xiao Yan ^a   Li, Tang ^a   Yan, Li ^a   Liu, Qing Shan ^a   Tian, Yu ^b  

^a MINZU UNIVERSITY OF CHINA   (China)

^b Beijing Municipal Public Security Bureau   (China)

Author keywords

Concanavalin A; Cytokines; Liver injury; Tanshinone IIA

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TANSHINONE IIA; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE INJURY; IMMUNOHISTOCHEMISTRY; LIVER INJURY; LIVER PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE SUBPOPULATION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CONCANAVALIN A; CYTOKINES; LIVER; LYMPHOCYTE ACTIVATION; MALE; MICE; PHENANTHRENES; T-LYMPHOCYTE SUBSETS;

MUS; SALVIA MILTIORRHIZA;

EID: 77249083160     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923970903120997     Document Type: Article

References (15)

1. Cheng, T.O. Cardiovascular effects of Danshen. Into J Cardio 2007; 121: 9-22.
2. Zhou, L.Z., Zoo, Z., Chow, M.S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clint Pharmacology 2005; 45: 1345-1359
3. Adams, J.D., Wang, R., Yang J., et al. Preclinical and clinical examinations of Salvia miltiorrhiza and its tensions in ischemic conditions. Chin Med 2006; 1: 3.
4. Liu, J.R., Chen, G.F., Shih, H.N., et al. Enhanced antioxidant bioactivity of Salvia miltiorrhiza (Danshen) products prepared using nanotechnology. Phytomedicine 2008; 15: 23-30.
5. Xiaohui, Z., Xinfeng, Z., Xin, Z., et al. Determination of the main bioactive metabolites of Radix salvia miltiorrhizae in compound Danshen dripping pills and the tissue distribution of Danshensu in rabbit by SPE-HPLC-MSn. J Sep Sci 2007; 30: 851-857
6. Herkel, J., Schuchmann, M., Tiegs, G., et al. Immune-mediated liver injury. J Hepatol 2005; 42: 920-923
7. Center, S.A. Chronic liver disease: current concepts of disease mechanisms. J Small Anim Pract 1999; 40: 106-114
8. Gantner, F., Leist, M., Lohse, A.W., et al. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology, 1995; 21: 190-198
9. Abboud, G., Kaplowitz, N. Drug-induced liver injury. Drug Saf 2007; 30: 277-294
10. Eksteen, B., et al. Immune-mediated liver injury. Semin Liver Dis 2007; 27: 351-366
11. Kremer, A.E., Rust, C., Eichhorn, P., et al. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers. Expert Rev Mol Diagn 2009; 9: 139-156
12. Beldi, G., Banz, Y., Nowak, M., et al. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology 2008; 48: 841-852
13. Huang, W., Dong, Z., Wei H., et al. Selective elimination of hepatic natural killer T cells with concanavalin A improves liver regeneration in mice. Liver Int 2006; 26: 339-345
14. Irshad, M.I., Khushboo, I., Singh, S. Hepatitis C virus (HCV): a review of immunological aspects. Int Rev Immunol 2008; 27: 497-517.
15. Ju, C. Immunological mechanisms of drug-induced liver injury. Curr Opin Drug Discov Dev 2005; 8: 38-43.